Sun Royal Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 9 Days
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 0.50 M
About Sun Royal Pharmaceuticals
Sun Royal Pharmaceuticals Private Limited (SRPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 January 2008 and has a history of 17 years. Its registered office is in Bathinda, Punjab, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Deepak Mehta and Sanjeev Kumar serve as directors at the Company.
Company Details
-
Location
Bathinda, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232PB2008PTC031624
-
Company No.
031624
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2008
-
Date of AGM
29 Sep 2012
-
Date of Balance Sheet
31 Mar 2012
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Sun Royal Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Mehta
|
Director | 29-Jan-2008 | Current |
|
Sanjeev Kumar
|
Director | 29-Jan-2008 | Current |
Financial Performance of Sun Royal Pharmaceuticals.
Enhance accessibility to Sun Royal Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sun Royal Pharmaceuticals?
Unlock access to Sun Royal Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2008 | Oriental Bank Of Commerce | ₹0.50 M | Open |
How Many Employees Work at Sun Royal Pharmaceuticals?
Unlock and access historical data on people associated with Sun Royal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Royal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Royal Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.